CD274 and neoplasm: Interestingly, tumor BECs also express a variety of immunosuppressive receptors, such as FasL, CD73, VACM-1, and programmed cell death ligand 1 (PD‐L1, CD274), which are involved in impeding the infiltration of immune effector cells in the adjoining tissue around the vessel (3, 4).